TWO SIGMA ADVISERS, LP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$14,896,760
+408.4%
922,400
+1206.5%
0.04%
+442.9%
Q2 2023$2,929,900
-13.2%
70,600
+25.8%
0.01%
-22.2%
Q1 2023$3,373,854
-67.6%
56,100
-60.5%
0.01%
-69.0%
Q4 2022$10,408,365
-24.6%
141,900
-21.9%
0.03%
-27.5%
Q3 2022$13,813,000
-5.8%
181,800
-13.9%
0.04%
-4.8%
Q2 2022$14,671,000
-34.0%
211,100
-21.3%
0.04%
-28.8%
Q1 2022$22,229,000
-2.4%
268,300
-11.5%
0.06%
+3.5%
Q4 2021$22,764,000
-40.0%
303,200
-7.2%
0.06%
-41.8%
Q3 2021$37,953,000
-45.7%
326,700
+3.6%
0.10%
-46.7%
Q2 2021$69,940,000
+17.1%
315,300
-30.2%
0.18%
+12.2%
Q1 2021$59,732,000
-28.2%
451,900
-6.0%
0.16%
-26.1%
Q4 2020$83,215,000
+14.4%
480,900
-26.4%
0.22%
+6.7%
Q3 2020$72,763,000
+38.6%
653,700
-26.2%
0.21%
+35.1%
Q2 2020$52,510,000
+25.1%
885,500
+42.0%
0.15%
-4.3%
Q1 2020$41,980,000
-44.2%
623,400
-30.2%
0.16%
-8.0%
Q4 2019$75,278,000
+12.5%
893,300
-0.1%
0.18%
+6.7%
Q3 2019$66,891,000
+72.8%
894,500
+46.1%
0.16%
+70.8%
Q2 2019$38,716,000
+51.3%
612,300
+15.2%
0.10%
+47.7%
Q1 2019$25,593,000
+211.4%
531,300
+116.4%
0.06%
+195.5%
Q4 2018$8,219,000
-56.8%
245,500
-32.3%
0.02%
-52.2%
Q3 2018$19,011,000
+146.4%
362,800
+47.2%
0.05%
+119.0%
Q2 2018$7,715,000
+1034.6%
246,500
+690.1%
0.02%
+950.0%
Q1 2018$680,000
+222.3%
31,200
+198.6%
0.00%
+100.0%
Q4 2017$211,00010,4490.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders